CXCR2 and neoplasm: Co-expression of the matched chemokine receptor CXCR2 in 2nd generation CAR T-cells targeted to the integrin αvβ6 results in increased migration in response to recombinant hIL-8 and to tumor-cell derived supernatant in an IL-8-mediated manner, without affecting cytotoxic function.